Daiichi Sankyo Company, Limited, a leading Japanese pharma, excels in ADC technology, with flagship product Enhertu driving significant revenue growth and global market leadership. Strong ...

(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Tuesday said Datroway has secured EU approval to treat breast cancer patients. Daiichi Sankyo, a Tokyo-based pharmaceutical company ...

Max, the Warner Bros. Discovery streaming service, launched a new black-and-white color palette that evokes the same ...

Daiichi Sankyo (DSNKY) and AstraZeneca’s (AZN) Enhertu has been approved in the European Union as a monotherapy for the treatment of adult patients with unresectable or metastatic hormone ...

(RTTNews) - AstraZeneca Plc. (AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) Enhertu (trastuzumab deruxtecan) has been approved in the European Union as a treatment for adults with advanced breast ...

Max is trading its bright blue branding and logo for a black-and-white color palette that evokes HBO’s classic branding.

Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally. The company offers Enhertu to treat patients with HER2 positive ...

Max just got a new logo. Again. Two years after rebranding from HBO Max to just Max with new a bright blue-and-white logo, ...

Jefferies analyst Stephen Barker maintained a Buy rating on Daiichi Sankyo Company (DSKYF – Research Report) today and set a price target of Yen6,000.00. The company’s shares closed yesterday ...

Shares in Esperion Therapeutics lost more than half of their value after it disclosed a dispute with Daiichi Sankyo on a $300 million milestone payment relating to cholesterol drug Nexletol.

A black-and-white video shared online for years is the only known recorded footage of German diarist Anne Frank. For years, a ...

by Good Morning Washington TOPICS: WASHINGTON (7News) — Daiichi Sankyo Inc., an innovative pharmaceutical company's deep ties to the Cherry Blossoms in Washington, DC dates back more than a ...